PDCD1LG2 and neoplasm: Additionally, PDCD1LG2 is associated with T cell exhaustion, and its modulation by TCF-1 indicates that overexpression may delay the onset of exhaustion, thereby extending the functional lifespan of CAR-T cells and enhancing their sustained anti-tumor activity (41–43).